Polymer-Free Drug-Coated Coronary Stents Are Cost-Effective in Patients at High Bleeding Risk: Economic Evaluation of the LEADERS FREE Trial.

MLA

Filipovic-Pierucci, Antoine, et al. “Polymer-Free Drug-Coated Coronary Stents Are Cost-Effective in Patients at High Bleeding Risk: Economic Evaluation of the LEADERS FREE Trial.” EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, vol. 13, no. 14, Feb. 2018, pp. 1688–95. EBSCOhost, https://doi.org/10.4244/EIJ-D-17-00286.

APA

Filipovic-Pierucci, A., Durand-Zaleski, I., Butel, T., Greene, S., Hovasse, T., Iñiguez, A., Nazzaro, M. S., Oldroyd, K. G., Talwar, S., Richardt, G., Windhovel, U., Urban, P., & Morice, M.-C. (2018). Polymer-Free Drug-Coated Coronary Stents Are Cost-Effective in Patients at High Bleeding Risk: Economic Evaluation of the LEADERS FREE Trial. EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 13(14), 1688–1695. https://doi.org/10.4244/EIJ-D-17-00286

Chicago

Filipovic-Pierucci, Antoine, Isabelle Durand-Zaleski, Thibault Butel, Samantha Greene, Thomas Hovasse, Andres Iñiguez, Marco Stefano Nazzaro, et al. 2018. “Polymer-Free Drug-Coated Coronary Stents Are Cost-Effective in Patients at High Bleeding Risk: Economic Evaluation of the LEADERS FREE Trial.” EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 13 (14): 1688–95. doi:10.4244/EIJ-D-17-00286.